Dupont Capital Management’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-28,883
Closed -$387K 1085
2022
Q4
$387K Buy
+28,883
New +$387K 0.02% 617
2021
Q4
Sell
-22,262
Closed -$480K 1806
2021
Q3
$480K Sell
22,262
-3,147
-12% -$75.8K 0.02% 910
2021
Q2
$734K Hold
25,409
0.02% 767
2021
Q1
$620K Sell
25,409
-5,211
-17% -$118K 0.01% 826
2020
Q4
$595K Sell
30,620
-2,286
-7% -$42K 0.01% 780
2020
Q3
$573K Sell
32,906
-2,204
-6% -$47K 0.01% 691
2020
Q2
$922K Sell
35,110
-21,546
-38% -$535K 0.02% 549
2020
Q1
$1.37M Sell
56,656
-9,581
-14% -$234K 0.03% 371
2019
Q4
$1.65M Buy
66,237
+26,387
+66% +$612K 0.04% 406
2019
Q3
$850K Sell
39,850
-4,272
-10% -$117K 0.02% 583
2019
Q2
$1.4M Buy
44,122
+27,940
+173% +$876K 0.03% 457
2019
Q1
$534K Hold
16,182
0.01% 736
2018
Q4
$520K Hold
16,182
0.01% 711
2018
Q3
$694K Hold
16,182
0.02% 657
2018
Q2
$745K Buy
+16,182
New +$716K 0.02% 617
2016
Q2
Sell
-7,578
Closed -$205K 694
2016
Q1
$205K Sell
7,578
-20,111
-73% -$577K ﹤0.01% 607
2015
Q4
$834K Sell
27,689
-3,802
-12% -$122K 0.02% 503
2015
Q3
$996K Buy
+31,491
New +$1.15M 0.03% 453

Other funds holding PAHC

Dupont Capital Management's PAHC Position: Q1 2023 in Review

Dupont Capital Management sold out of Phibro Animal Health (PAHC) in Q1 2023, closing a stake of 28,883 shares — an estimated $387K sold.

Dupont Capital Management first reported a position in PAHC in Q3 2015 and held it in 18 quarters. The position peaked at $1.65M in Q4 2019. 133 funds tracked by Wall St. Rank hold PAHC as of Q1 2023.

  • Dupont Capital Management reported no remaining Phibro Animal Health position as of Q1 2023 after selling out during the quarter.
  • Dupont Capital Management sold 28,883 Phibro Animal Health shares in Q1 2023, an estimated $387K.
  • Dupont Capital Management first reported a position in Phibro Animal Health in Q3 2015 and held it in 18 quarters.
  • Dupont Capital Management's Phibro Animal Health position peaked at $1.65M in Q4 2019.
  • 133 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2023.

Based on Dupont Capital Management's 13F filing for Q1 2023, filed 28 Apr 2023.